Study Summary
An Open-Label, Non-Randomized, uncontrolled, single-dose pilot study of VGB-R04 in subjects with Hemophilia B.
Want to learn more about this trial?
Request More InfoInterventions
VGB-R04GENETIC
A novel, bioengineered adeno-associated viral (AAV) vector carrying human factor IX variant
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Blood diseases hospital | Tianjin | Tianjin Municipality | China |